By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Bristol-Myers Squibb Company 

345 Park Avenue

New York  New York  10154  U.S.A.
Phone: 212-546-4000 Fax: 212-546-4020


SEARCH JOBS

Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases.

YEAR FOUNDED:

1858

LEADERSHIP:

Founder: Edward Robinson Squibb

CEO: Giovanni Caforio, MD

CFO: Charles Bancroft

CLINICAL TRIAL:

Please click here for clinical trial information.

JOB OPPORTUNITY:

Please click here for Bristol-Myers Squibb job opportunities.

PRODUCTS:

Please click here to see all products.

For more information, visit
www.bms.com and follow us on www.twitter.com/BMSNEWS.

FOLLOW BRISTOL-MYERS SQUIBB:





Key Statistics


Email:
Ownership: Public

Web Site: Bristol-Myers Squibb
Employees:
Symbol: BMY
 





Collaborations

Gilead 

PanVera LLC 

Pharmagene Laboratories Limited 

Johnson & Johnson 

Amersham Biosciences 

Lexicon Genetics Incorporated 

Athersys  Athersys will provide Bristol-Myers Squibb with cell lines expressing validated drug targets produced using the RAGE-Validated Target technology. BMS plans to use its combinatorial chemistry capabilities to develop small molecule drug candidates against the validated targets.

Merck & Co.  Diabetes

Affinimark Technologies Inc. 

GlaxoSmithKline (North Carolina) 

Medarex, Inc. 

Gilead (Durham, NC) 

Phyton Biotech  - Cancer

Gilead (Seattle, WA) 





Company News
Merck & Co. (MRK)'s Keytruda May Have an Edge Over Bristol-Myers Squibb (BMY)'s Opdivo for Cancer Doctors 8/26/2016 6:17:38 AM
Biotechs are Expanding in the Bay Area Again: Bristol-Myers Squibb (BMY), Genentech (RHHBY), Gilead (GILD), Illumina (ILMN) and Verily and More 8/26/2016 6:02:19 AM
Bristol-Myers Squibb (BMY) And Pfizer (PFE) To Present New Eliquis (Apixaban) Analyses At European Society of Cardiology Congress 2016 8/23/2016 10:06:02 AM
Editas Medicine Nabs Former Bristol-Myers Squibb (BMY) Exec as New CSO 8/22/2016 6:40:18 AM
AVEO Oncology (AVEO) Initiates The Evaluation Of Tivozanib In Combination With Bristol-Myers Squibb (BMY)’s Opdivo (Nivolumab) In Advanced Renal Cell Carcinoma 8/15/2016 11:58:09 AM
Bavarian Nordic (BAVA.CO) Announces Drug Supply Agreement With Bristol-Myers Squibb (BMY) For NSCLC Clinical Study 8/15/2016 9:45:44 AM
Bristol-Myers Squibb (BMY) Investors: Wait on Opdivo Data to See Potential in Lung Cancer 8/15/2016 8:54:41 AM
A Gilead (GILD) and Bristol-Myers Squibb (BMY) Merger—Let Us Count the Ways 8/12/2016 6:09:52 AM
Bristol-Myers Squibb (BMY) Reacquires Rights to ASLAN002 (BMS777607) From ASLAN in $60 Million+ Deal 8/10/2016 6:13:50 AM
Bristol-Myers Squibb (BMY)'s $4 Billion Disaster Sends Partner Ono Pharma (OPHLY)'s Stock Plunging 8/8/2016 6:34:42 AM
12345678910...
//-->